Pharmaceutical Anti-counterfeiting Technologies Market Trends Research And Projections For 2018-2026

1. Pharmaceutical Anti-counterfeiting Technologies Pharmaceutical Anti-counterfeiting Technologies Market - Size, Share, Growth, Outlook, and Market - Size, Share, Growth, Outlook, and Opportunity Analysis, 2018-2026 Opportunity Analysis, 2018-2026 Pharmaceutical products are one of the most vulnerable goods for counterfeiting practices worldwide. Counterfeiting practices involve substitution of original medicine with substandard drug containing toxic substance or no active ingredient at all. Anti-counterfeiting technologies are applied to nullify adverse impact on health of patients, which may lead to death of patient in extreme cases. Pharmaceutical industry has one of the highly complex supply chain management network, which makes it relatively difficult to track products from end to end platform, thereby increasing demand for counterfeiting practice. Unlike other products in which counterfeiting practices could be identified with visual appearance of the product by the end user, pharmaceutical products could not be identified for their spurious content by the end user or other stake holder. Moreover, various patented products of high price are counterfeited with spurious content to gain high profit. Anti-counterfeiting technologies consist of different types such as track and trace technologies, cohort technologies, overt technologies, and forensic technologies. Drugs that are commonly counterfeited include birth control drugs, anti- malarial, and other lifesaving drugs. Although there is a rapid change in technology landscape such as availability of smartphones, burden of anti-counterfeiting practices are increasingly shared by the end users. Request Sample Copy of Research Report: https://www.coherentmarketinsights.com/insight/request-sample/1747 Market Dynamics Pharmaceutical anti-counterfeiting technologies market is majorly driven by the increasing incidence of counterfeiting medicines affecting patient health and overall human capital. According to the International Trade Administration Top Market Reports on Pharmaceuticals published in 2016, the global market for counterfeit drugs valued at number of US$ 75 - 200 billion, which is a serious threat to the health of people worldwide. In 2017, the Pharmaceutical Security Institute (PSI) report stated a rise in drug diversion incidents around the world, which includes diversion of medicines supplied for compassionate use.

2. Regional Insights On the basis of region, the global pharmaceutical anti-counterfeiting technologies market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America holds a dominant position in the market due to rising number of counterfeit drugs and stringent regulations related to counterfeit drugs. It is observed that the FDA seized nearly US$ 73 million in counterfeit drugs in the year 2014. Moreover, the opioid addiction has led to increased levels of counterfeit opioids such as fentanyl. The U.S. enacted legislations such as the U.S. Drug Supply Chain Security Act (DSCSA) in 2017 that mandates pharmaceutical manufacturers to identify pharmaceuticals at the unit package level, in order to trace the product within the supply chain. This is done to prevent pharmaceutical product counterfeiting. Moreover, Asia Pacific is expected to witness significant growth in the market over the forecast period due to the maximum number of counterfeit drugs available in this region. According to The World Health Organization (WHO) fact sheet 2017, around 1 in 10 medical products used in low- and middle-income economies are either substandard or falsified and up to 30 per cent of branded drugs sold in these economies are counterfeit. According to the Pharmaceutical Security Institute in 2017, maximum arrest (51%) cases in association with the counterfeiting of pharmaceuticals are observed in Asia Pacific. Report includes chapters which deeply display the following deliverable about industry : • Pharmaceutical Anti-counterfeiting Technologies Market Research Objective and Assumption • Pharmaceutical Anti-counterfeiting Technologies Market Purview - Report Description, Executive Summary, and Coherent Opportunity Map (COM) • Pharmaceutical Anti-counterfeiting Technologies Market Dynamics, Regulations, and Trends Analysis - Market Dynamics, Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST Analysis • Global Pharmaceutical Anti-counterfeiting Technologies Market, By Regions • Pharmaceutical Anti-counterfeiting Technologies Market Competition by Manufacturers including Production, Share, Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type. • Pharmaceutical Anti-counterfeiting Technologies Market Manufacturers Profiles/Analysis including Company Basic Information, Manufacturing Base and Its Competitors. • Pharmaceutical Anti-counterfeiting Technologies Market Manufacturing Cost Analysis including Key Raw Materials and Key Suppliers of Raw Materials. • Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials Sourcing and Downstream Buyers • Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market Positioning and Distributors/Traders List. • Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer Preference Change and Economic/Political Environmental Change.

3. • Pharmaceutical Anti-counterfeiting Technologies Market Forecast including Production, Consumption, Import and Export Forecast by Type, Applications and Region. • Research Findings and Conclusion Key players operating in the pharmaceutical anti-counterfeiting technologies market include Alien Technology, Alpvision, Robert Bosch GmbH, 3M Company, Angstrom Technologies, Thermo Fisher Scientific, Authentix, Inc., Avery Dennison Corporation, Colorcon, Covectra, and Everest Holovisions Ltd. Inquire Here Before Purchase: https://www.coherentmarketinsights.com/insight/talk-to-analyst/1747 Market Taxonomy On the basis of product type, the global pharmaceutical anti-counterfeiting technologies market is segmented into: RFID Bar coding QR Coding Holography Security Ink Taggants Others • • • • • • • On the basis of technology, the global pharmaceutical anti-counterfeiting technologies market is segmented into: Overt Technologies Cohort Technologies Forensic Technologies Track and Trace Technologies Others • • • • • On the basis of geography, the global pharmaceutical anti-counterfeiting technologies market is segmented into: North America Latin America Europe Asia Pacific • • • •

4. Middle East Africa • • About Coherent Market Insights Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity. Contact Us Mr. Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: +1-206-701-6702 Email: sales@coherentmarketinsights.com